The consumer reported a conflicting results withbinaxnow covid-19 antigen self test performed on (b)(6) 2022 with an unknown sample.Consumer stated that the first test generated a positive result.The consumer retested with another binaxnow within one hour of the first test which generated a negative result.Although requested, no additional patient information, including treatment and outcome, was provided.
|
Additional information : d4.Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 182479 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 195-160 / lot 182479 and test base part number 195-430h / lot 180011.The lot met the required release specifications.A review of the complaints reported as false positive and false negative patient results (confirmed and unconfirmed, conflicting results) related to kit lot 182479 showed that the complaint rate is (b)(4) respectively.In conclusion, abbott diagnostics scarborough was unable to determine the exact root cause of the reported issue; however, it could possibly be related to issues including the self-test user performance, interpretation of the result, or the specific patient sample.
|